| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/29/1999 | WO1999037619A1 Chemokine receptor antagonists and methods of use therefor |
| 07/29/1999 | WO1999037617A1 Chemokine receptor antagonists and methods of use therefor |
| 07/29/1999 | WO1999037616A1 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 07/29/1999 | WO1999037614A1 Azetidinecarboxamide derivatives for the treatment of cns disorders |
| 07/29/1999 | WO1999037613A1 Azetidinecarboxamide derivatives for treating cns disorders |
| 07/29/1999 | WO1999037612A1 Azetidinecarboxamide derivatives for treating cns disorders |
| 07/29/1999 | WO1999037606A1 New derivatives of sulfonic, phosphonic and phosphinic aminoalkane acids, their production and their use as medicaments |
| 07/29/1999 | WO1999037326A1 Biologically active hemagglutinin from type a clostridium botulinum and methods of use |
| 07/29/1999 | WO1999037314A1 Sea cucumber carotenoid lipid fraction products and methods of use |
| 07/29/1999 | WO1999037310A1 Methods of decreasing or preventing pain using spicamycin or derivatives thereof |
| 07/29/1999 | WO1999037305A1 Pharmaceutically active morpholinol |
| 07/29/1999 | WO1999037304A1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS |
| 07/29/1999 | WO1999037303A1 Combination of a gaba-a alpha 2/3 agonist and a selective serotonin reuptake inhibitor |
| 07/29/1999 | WO1999037302A1 Extended release tiagabine formulations with reduced side-effects |
| 07/29/1999 | WO1999037297A1 Pig appeasing pheromones to decrease stress, anxiety and aggressiveness |
| 07/29/1999 | WO1999037294A2 Mitochondria protecting agents for treating mitochondria associated diseases |
| 07/29/1999 | WO1999021617A3 Allosteric adenosine receptor modulators |
| 07/29/1999 | WO1999019306A3 2,3-benzodiazepin-2-one derivatives, their preparation and their use as inhibitors of protein tyrosine kinases |
| 07/29/1999 | DE19802450A1 New saccharide compounds useful in treating schizophrenia |
| 07/29/1999 | CA2319131A1 Mitochondria protecting agents for treating mitochondria associated diseases |
| 07/29/1999 | CA2319113A1 Biologically active hemagglutinin from type a clostridium botulinum and methods of use |
| 07/29/1999 | CA2319077A1 Chemokine receptor antagonists and methods of use therefor |
| 07/29/1999 | CA2318952A1 Triazolo-pyridazine derivatives as ligands for gaba receptors |
| 07/29/1999 | CA2318935A1 Phagocytosis genes and uses thereof |
| 07/29/1999 | CA2318448A1 Extended release tiagabine formulations with reduced side-effects |
| 07/29/1999 | CA2318303A1 Secreted proteins and polynucleotides encoding them |
| 07/29/1999 | CA2318268A1 Pharmaceutically active morpholinol |
| 07/29/1999 | CA2318100A1 Chemokine receptor antagonists and methods of use therefor |
| 07/29/1999 | CA2318088A1 Chemokine receptor antagonists and methods of use therefor |
| 07/29/1999 | CA2317740A1 Sulphonamide derivatives for treatment of cns disorders |
| 07/29/1999 | CA2317577A1 Methods of decreasing or preventing pain using spicamycin or derivatives thereof |
| 07/29/1999 | CA2317486A1 Triazolo-pyridazine derivatives as ligands for gaba receptors |
| 07/29/1999 | CA2317484A1 Triazolo-pyridazine derivatives as ligands for gaba receptors |
| 07/29/1999 | CA2317424A1 Combination of a gaba-a alpha 2/3 agonist and a selective serotonin reuptake inhibitor |
| 07/29/1999 | CA2317422A1 Triazolo-pyridazine derivatives as ligands for gaba receptors |
| 07/29/1999 | CA2315763A1 Triazolo-pyridazine derivatives as ligands for gaba receptors |
| 07/29/1999 | CA2315213A1 Triazolo-pyridazine derivatives as ligands for gaba receptors |
| 07/29/1999 | CA2311729A1 Purified populations of stem cells |
| 07/28/1999 | EP0931551A1 Diagnostics and therapeutics for transmissible spongiform encephalopathy and method for the manufacture of non-infective blood products and tissue derived products |
| 07/28/1999 | EP0931547A1 Piperazinyl-heterocyclic compounds in the treatment of psychiatric conditions |
| 07/28/1999 | EP0931159A2 Non-mammalian dna virus having an altered coat protein |
| 07/28/1999 | EP0931145A1 Ptx sensitive g proteins, the production and use thereof |
| 07/28/1999 | EP0931144A1 Novel human phospholemman-like protein |
| 07/28/1999 | EP0931138A1 Method of producing a thymic microenvironment that supports the development of dendritic cells |
| 07/28/1999 | EP0931087A1 Novel pyranoside derivatives |
| 07/28/1999 | EP0931081A1 Pyridazino 4,5-b]-quinoline 5-oxide derivatives, their preparation and their use as glycine antagonists |
| 07/28/1999 | EP0931075A1 Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf) |
| 07/28/1999 | EP0931067A1 D4 receptor selectivity piperazine derivatives |
| 07/28/1999 | EP0931056A1 N-substituted-2-amino-4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibitory activity |
| 07/28/1999 | EP0930891A1 Oral administration of chicken yolk antibodies to treat disease |
| 07/28/1999 | EP0930887A2 Cancer immunotherapy using tumor cells combined with mixed lymphocytes |
| 07/28/1999 | EP0930883A1 Neurotrophin antagonist compositions |
| 07/28/1999 | EP0737189B1 Heterocyclic compounds for the treatment of cns and cardiovascular disorders |
| 07/28/1999 | EP0705265B1 Novel chemical compounds having pde-iv inhibition activity |
| 07/28/1999 | EP0604494B1 5-ht4 receptor antagonists |
| 07/28/1999 | CN1224464A Growth factor and genetic sequence encoding same |
| 07/28/1999 | CN1224424A Azolobenzazepine derivs. as neurologically active agents |
| 07/28/1999 | CN1224350A Use of topiramate or derivs. thereof for manufacture of medicament for treatment of manic-depressive bipolar disorders |
| 07/28/1999 | CN1224011A New heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/28/1999 | CN1223874A Medicine for abstaining from drug and preparing process thereof |
| 07/28/1999 | CN1044367C (S)-alpha-phenyl-2-pyridine-ethylamine, its preparing method and composition contg. same |
| 07/28/1999 | CN1044365C Alpha, omega-diarylalkane derivs., their preparation and their use in treatment and prevention of circulatory diseases and psychosis |
| 07/27/1999 | US5929247 Heterocyclic compounds and their preparation and use |
| 07/27/1999 | US5929237 Conformationally constrained compounds which mimic the secondary structure of reverse-turn regions of biologically active peptides and proteins; for random drug screening |
| 07/27/1999 | US5929236 2-substituted morpholine and thiomorpholine derivatives as GABA-B antagonists |
| 07/27/1999 | US5929223 Nucleotide sequence of drosophila cyclic 3',5'-adenosine monophosphate responsive transcriptional activator and antagonist |
| 07/27/1999 | US5929210 Purified polypeptide of irreversible, extracellular serine protease inhibitor; for diagnosis/treatment of related diseases; antitumor agents; cushing's/alzheimer's/parkinson's diseases; dwarfism; eating disorders |
| 07/27/1999 | US5929122 Combination preparation containing tramadol and a calcium channel antagonist |
| 07/27/1999 | US5929088 Treatment of epilepsy, fainting, neurodegenerative disorders, anxiety, pain, panic attacks |
| 07/27/1999 | US5929084 Treating myasthenia by inhibiting cholinesterase comprising administering huperazine a derivative to the patient |
| 07/27/1999 | US5929078 Antiserotonine agent |
| 07/27/1999 | US5929072 Treatment of central nervous system disorders |
| 07/27/1999 | US5929070 Method for treating migraine pain with olanzapine |
| 07/27/1999 | US5929067 N-acylating amine derivative of caprolactam compound with a carboxylic acid or derivatives to form amide derivative of caprolactam compound |
| 07/27/1999 | US5929065 Adminsitering a patient suffering from sleep disorder a hypnotically effective amount of 4,5,6,7-tetrahydroisoxaxole(5,4-c)pyridine-3-ol(thip) |
| 07/27/1999 | US5929063 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 07/27/1999 | US5929061 Method for treating vascular headaches |
| 07/27/1999 | US5929041 Method for preventing and treating sensorineural hearing loss and vestibular disorders using glial cell line-derived neurotrophic factor(GDNF) protein product |
| 07/27/1999 | US5929032 Method for treating Schwann and colon cells in vitro |
| 07/27/1999 | US5929029 Human calcium-binding phosphoprotein |
| 07/27/1999 | CA2170700C Pyrazolopyrimidines and pyrrolopyrimidines for treatment of neuronal and other disorders |
| 07/27/1999 | CA2164804C Nk-1 receptor antagonists for the treatment of neuronal injury and stroke |
| 07/27/1999 | CA2155837C Benzopyrans as potassium channel openers |
| 07/27/1999 | CA2025663C Indole derivatives |
| 07/22/1999 | WO1999036426A1 N-[2-(5-BENZYLOXYCARBONYL-AMINO-6-OXO-2-(4-FLUOROPHENYL)-1,6-DIHYDRO-1-PYRIMIDINYL)ACETO- XYL]-L-ASPARTIC ACID ALDEHYDE AS AN IN VIVO INHIBITOR OF INTERLEUKIN-1β CONVERTING ENZYME (ICE) |
| 07/22/1999 | WO1999036424A1 Piperazino derivatives as neurokinin antagonists |
| 07/22/1999 | WO1999036423A1 Triazolo-pyridazine derivatives as ligands for gaba receptors |
| 07/22/1999 | WO1999036421A1 4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists |
| 07/22/1999 | WO1999036420A1 Thiophene nitrone compounds |
| 07/22/1999 | WO1999036418A1 Substituted bicyclic lactones |
| 07/22/1999 | WO1999036417A1 SUBSTITUTED β,η-ANELLATED LACTONES |
| 07/22/1999 | WO1999036416A1 SUBSTITUTED α,β-ANELLATED BUTYROLACTONES |
| 07/22/1999 | WO1999036415A1 Thioether furan nitrone compounds |
| 07/22/1999 | WO1999036398A1 Aminosulphonylbenzamide derivatives as modulators of the activity of neuronal calcium channels |
| 07/22/1999 | WO1999036392A1 Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same |
| 07/22/1999 | WO1999036083A1 Methods of neuroendocrine regulation of affective disorders |
| 07/22/1999 | WO1999036080A1 St. john's wort and methyl donor composition and uses thereof |
| 07/22/1999 | WO1999036078A1 Analgesic from snake venom |
| 07/22/1999 | WO1999036077A1 Composition and method for treatment and prevention of arthritis and/or autoimmune diseases |
| 07/22/1999 | WO1999036069A1 Il-8 receptor antagonists |